NorthWest Biotherapeutics Inc (NWBO)

[HyGro]

7 journal articles point out the clear bias of redoing the protocol TWO WEEKS before the end of the trial. In addition, FDA Guideline for an external comparator requires the comparators be selected and approved BEFORE the trial begins. NWBO did it two weeks before the trial was CONCLUDED.

Sorry, I'll believe the seven journal articles that all conclude the bias built into all the protocol changes including external comparator. Notice NWBO didn't even file an application with the FDA. They know the FDA would reject the complete protocol change two weeks before the end of the trial.